BR0114105A - Bactérias de acido lático capazes de reduzir uma tendência do indivìduo para desenvolver reações alérgicas - Google Patents

Bactérias de acido lático capazes de reduzir uma tendência do indivìduo para desenvolver reações alérgicas

Info

Publication number
BR0114105A
BR0114105A BR0114105-8A BR0114105A BR0114105A BR 0114105 A BR0114105 A BR 0114105A BR 0114105 A BR0114105 A BR 0114105A BR 0114105 A BR0114105 A BR 0114105A
Authority
BR
Brazil
Prior art keywords
individual
lactic acid
allergic reactions
tendency
reducing
Prior art date
Application number
BR0114105-8A
Other languages
English (en)
Inventor
Jacques Edouard Germond
Blaise Corthesy
Beat Mollet
Rodolphe Fritsche
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of BR0114105A publication Critical patent/BR0114105A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1236—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt using Leuconostoc, Pediococcus or Streptococcus sp. other than Streptococcus Thermophilus; Artificial sour buttermilk in general
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C2220/00—Biochemical treatment
    • A23C2220/20—Treatment with microorganisms
    • A23C2220/202—Genetic engineering of microorganisms used in dairy technology
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/151—Johnsonii
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/21—Streptococcus, lactococcus
    • A23V2400/231—Lactis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Dairy Products (AREA)

Abstract

"BACTéRIAS DE áCIDO LáTICO CAPAZES DE REDUZIR UMA TENDêNCIA DO INDIVìDUO PARA DESENVOLVER REAçõES ALéRGICAS". A presente invenção refere-se a novas cepas de bactérias de ácido lático que são capazes de reduzir uma tendência do indivíduo a aumentar reações alérgicas. Em particular, a presente invenção refere-se a geração de cepas de bactérias de ácido lático que expressam proteínas incluindo peptídeos tolerogênicos e o emprego destes na redução de uma tendência do indivíduo a aumentar reações alérgicas. A invenção também pertence a composições alimentícias ou farmacêuticas contendo os referidos microrganismos ou frações ativas destes.
BR0114105-8A 2000-09-25 2001-09-21 Bactérias de acido lático capazes de reduzir uma tendência do indivìduo para desenvolver reações alérgicas BR0114105A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00120867 2000-09-25
PCT/EP2001/010956 WO2002024883A2 (en) 2000-09-25 2001-09-21 Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions

Publications (1)

Publication Number Publication Date
BR0114105A true BR0114105A (pt) 2003-07-29

Family

ID=8169939

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0114105-8A BR0114105A (pt) 2000-09-25 2001-09-21 Bactérias de acido lático capazes de reduzir uma tendência do indivìduo para desenvolver reações alérgicas

Country Status (21)

Country Link
US (1) US7498162B2 (pt)
EP (1) EP1379635A2 (pt)
JP (1) JP2004514424A (pt)
KR (1) KR20030034178A (pt)
CN (1) CN1246456C (pt)
AR (1) AR033574A1 (pt)
AU (2) AU2056102A (pt)
BG (1) BG107657A (pt)
BR (1) BR0114105A (pt)
CA (1) CA2420160A1 (pt)
CZ (1) CZ2003749A3 (pt)
HU (1) HUP0302585A3 (pt)
IL (1) IL154284A0 (pt)
MX (1) MXPA03001673A (pt)
NO (1) NO20031159L (pt)
NZ (1) NZ524527A (pt)
PL (1) PL365246A1 (pt)
RU (1) RU2294366C2 (pt)
SK (1) SK3642003A3 (pt)
WO (1) WO2002024883A2 (pt)
ZA (1) ZA200301244B (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1239032A1 (en) * 2001-03-02 2002-09-11 Société des Produits Nestlé S.A. Lactic acid bacteria as agents for treating and preventing allergy
EP1319410A1 (en) * 2001-12-11 2003-06-18 Société des Produits Nestlé S.A. Use of micro-organisms for a directed delivery of substances to specific parts of the gut
WO2004112773A1 (fr) * 2003-04-24 2004-12-29 Shin-Jen Shiao Compositions pharmaceutiques utilisees pour le traitement de maladie immune et amelioration
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
KR20070089231A (ko) * 2004-12-14 2007-08-30 알크-아벨로 에이/에스 이종 단백질성 화합물을 제시하는 박테리아 세포를포함하는 약제학적 조성물
WO2006097949A1 (en) * 2005-03-16 2006-09-21 Actial Farmacêutica, Lda. Mixture of at least 6 species of lactic acid bacteria and/or bifidobacteria in the manufacture of sourdough
CA2607949C (en) 2005-05-31 2012-09-25 Thomas William-Maxwell Boileau Feline probiotic bifidobacteria
DK1880001T3 (da) 2005-05-31 2011-09-12 Iams Company Feline probiotiske lactobacilli
US20100233318A1 (en) * 2006-03-31 2010-09-16 Luppo Edens Process for the hydrolysis of milk proteins
AU2008211600B8 (en) 2007-02-01 2014-02-13 Mars, Incorporated Method for decreasing inflammation and stress in a mammal using glucose antimetabolites, avocado or avocado extracts
US9771199B2 (en) * 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US9232813B2 (en) * 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
CA2749964A1 (en) * 2009-01-27 2010-08-05 Arla Foods Amba Long shelf life milk and milk-related products, and a process and milk processing plant for their manufacture
CA2761573A1 (en) * 2009-05-11 2010-11-18 Nestec S.A. Bifidobacterium longum ncc2705 (cncm i-2618) and immune disorders
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
PL3097791T3 (pl) * 2010-06-04 2018-10-31 N.V. Nutricia Niestrawne oligosacharydy do doustnej indukcji tolerancji na białka pokarmowe
EP3282260B1 (en) * 2011-09-02 2019-12-11 DH Technologies Development Pte. Ltd. System and method for detection of lactoglobulin
WO2013083140A1 (en) 2011-12-07 2013-06-13 N.V. Nutricia Beta-lactoglobulin peptides for treating cow's milk protein allergy
WO2016148562A1 (en) * 2015-03-18 2016-09-22 N.V. Nutricia Method for inducing oral tolerance via administration of beta-lactoglobulin derived peptide in combination with probiotic
CN105362296A (zh) * 2015-11-27 2016-03-02 成都吉氧屋科技有限公司 乳酸菌洗鼻液
WO2019212330A1 (en) * 2018-04-30 2019-11-07 N.V. Nutricia Formula with a specific beta-lactoglobulin peptide
WO2019212329A1 (en) * 2018-04-30 2019-11-07 N.V. Nutricia Formula with specific beta-lactoglobulin peptides
CN114149486B (zh) * 2021-05-28 2023-05-12 中国科学院大连化学物理研究所 一种抗菌肽mamp-01及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302855D0 (sv) * 1993-09-06 1993-09-06 Martin Lindberg Method and means for producing plasmaproteinase inhibitor binding proteins
US5817308A (en) * 1994-02-14 1998-10-06 University Of Rochester Tolerogenic fusion proteins of immunoglobulins and methods for inducing and maintaining tolerance
AU2149495A (en) * 1995-04-11 1996-10-30 Nederlandse Organisatie Voor Toegepast- Natuurwetenschappelijk Onderzoek Tno Method for the construction of vectors for lactic acid bacte ria like lactobacillus such that the bacteria can efficientl y express, secrete and display proteins at the surface
FI104465B (fi) * 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
GB9518323D0 (en) 1995-09-07 1995-11-08 Steidler Lothar Materials and methods relating to the attachment and display of substances on cell surfaces
US6100388A (en) * 1998-03-16 2000-08-08 Biogaia Biologies Ab Lactobacilli harboring aggregation gene as a vaccine delivery vehicle
MY129566A (en) 1999-01-19 2007-04-30 Nestle Sa A hypoallergenic composition containing tolerogenic peptides inducing oral tolerance

Also Published As

Publication number Publication date
AU2002220561B2 (en) 2007-01-11
EP1379635A2 (en) 2004-01-14
CZ2003749A3 (cs) 2003-06-18
AU2056102A (en) 2002-04-02
WO2002024883A2 (en) 2002-03-28
HUP0302585A3 (en) 2007-05-02
PL365246A1 (en) 2004-12-27
SK3642003A3 (en) 2003-08-05
KR20030034178A (ko) 2003-05-01
MXPA03001673A (es) 2003-06-09
ZA200301244B (en) 2004-05-14
IL154284A0 (en) 2003-09-17
WO2002024883A3 (en) 2003-11-06
AU2002220561C1 (en) 2002-04-02
JP2004514424A (ja) 2004-05-20
HUP0302585A2 (hu) 2003-10-28
AR033574A1 (es) 2003-12-26
NO20031159L (no) 2003-05-20
NZ524527A (en) 2005-05-27
CN1246456C (zh) 2006-03-22
US20040071714A1 (en) 2004-04-15
CA2420160A1 (en) 2002-03-28
NO20031159D0 (no) 2003-03-13
CN1479788A (zh) 2004-03-03
US7498162B2 (en) 2009-03-03
RU2294366C2 (ru) 2007-02-27
BG107657A (bg) 2003-12-31

Similar Documents

Publication Publication Date Title
BR0114105A (pt) Bactérias de acido lático capazes de reduzir uma tendência do indivìduo para desenvolver reações alérgicas
BR0113822A (pt) Vacina
AU2001254624A1 (en) Human coagulation factor vii variants
BR0008911A (pt) Bactérias patogênicas da cepa lactobacillus para a prevenção de diarréia
BR0206689A (pt) Combinação de probióticos, e, uso desta
BRPI0516437A (pt) utilização de uma quantidade eficaz de pelo menos um microorganismo, processo de tratamento cosmético, composição cosmética e/ou dermatológica e composição para absorção oral
BR0111275A (pt) Probióticos para aplicações de alimentos para animais de estimação
BR0008912A (pt) Cepas de bactérias do ácido láctico capazes de prevenir a diarréia
BRPI0417826A (pt) bifidobactéria pseudolongum probiótica canina
BRPI0114400B8 (pt) uso de bactéria de ácido lático probiótica para equilibrar o sistema imunológico da pele
BR0108173A (pt) Composições farmacêuticas de toxina de botulina
BR9406232A (pt) Novo agente para controle da atividade celular
BRPI0414722A (pt) meios sem produto animal e processos para obtenção de uma toxina botulìnica
DE60237645D1 (de) Immunstimulierendes Mittel enthaltend eine Biomasse von methanotrophem Bakterium
BRPI0417793A (pt) bifidobactéria globosum probiótica canina
BR0015698A (pt) Composições e métodos para tratamento de doenças alérgicas
AU1727797A (en) Heterocyclic biaryl compounds, pharmaceutical and cosmetic compositions containing them and uses thereof
SE9704584L (sv) Framställning av konjugerad linolsyra
DK0832057T3 (da) Diaromatiske propynyl- eller dienylforbindelser
FI850354L (fi) Kompositioner foer anvaendning vid kosmetisk, haelso- och kroppsvaord.
BRPI0302496C1 (pt) composições farmacêuticas com atividade antibiótica
BR0015102A (pt) Bactérias de ácido latico para o tratamento e/ou profilaxia de giardìase
ATE395064T1 (de) Kombinationspräparate von 3-n- formylhydroxylaminopropylphosphonsäurederivaten oder 3-n- acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
BR0012973B1 (pt) Uso de bactéria do ácido láctico pertencente ao gênero Bifidobacterium, e composição alimentícia ou farmacêutica.
BR9810452A (pt) Nova combinação de medicamentos contra asma

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A,10A E 11A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2172 DE 21/08/2012.